<DOC>
	<DOCNO>NCT00688168</DOCNO>
	<brief_summary>The goal research study learn pain and/or symptom patient may experience either monitored doctor decision make start treatment MM , treatment MM , symptom may affect therapy . A second goal learn difference gene may affect symptom burden cancer cancer therapy .</brief_summary>
	<brief_title>Inflammatory Cytokines Symptom Production Multiple Myeloma</brief_title>
	<detailed_description>If agree take part study , complete 5 questionnaire regularly schedule clinic visit . These questionnaire measure pain symptom , mood quality life . You also ask give tissue sample insert swab mouth rub firmly inside cheek underneath lower upper lip minute . Completing 5 questionnaire swab sample collection take 30 minute total . This investigational study . Up 500 patient take part cross-sectional phase study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>1 . Must speak understand English ; 2 . Must diagnose MM meet one follow criterion : 1 ) treat MM steroid , receive two cycle induction chemotherapy MM go treated bortezomib thalidomide induction therapy ; 2 ) receive induction therapy approve ( approve ) medically financially receive autologous hematopoietic stem cell transplantation ( AutoHSCT ) ; 3 ) cross sectional study patient either current diagnosis asymptomatic MM receiving treatment ; least 12 month MM diagnosis , receive induction therapy , without receive autologous hematopoietic stem cell transplantation ( AutoHSCT ) followup treatment . This cohort cross sectional survey may include case enrol , either complete drop study . It may also include patient participate first phase protocol ( longitudinal cohort ) . 3 . Patients &gt; = 18 year old . 1 . Patients understand intent study , give informed consent 2 . Patients unable use Interactive Voice Response ( IVR ) system due physical limitation ( e.g. , hear impairment ) . 3 . Induction therapy patient neuropathy score 3 great NCI 's Common Terminology Criteria ( CTC version 3.0 ) either begin induction chemotherapy 12 cycle chemotherapy result previous treatment comorbid cause . This exclusion criterion apply autoHSCT patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Phone Call</keyword>
	<keyword>Treatment Naive</keyword>
	<keyword>Inflammatory Cytokines</keyword>
	<keyword>Questionnaire</keyword>
	<keyword>Survey</keyword>
	<keyword>Interactive Voice Response</keyword>
	<keyword>Symptom Production</keyword>
	<keyword>Pain</keyword>
	<keyword>IVR</keyword>
	<keyword>MM</keyword>
</DOC>